1. Host–virus interactions in hepatitis B and hepatitis C infection

   • Sachiyo Yoshio
   • Tatsuya Kanto

   Review 19 February 2016 Pages: 409 - 420

   

2. Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma: evidence from a 10-year experience

   • Hitoshi Maruyama
   • Tadashi Sekimoto
   • Osamu Yokosuka

   Review 22 December 2015 Pages: 421 - 433

   

3. Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease

   • Shapur Ikhtaire
   • Mohammad Sharif Shajib
   • Waliul Islam Khan

   Review 20 February 2016 Pages: 434 - 446

   

4. Mouse model of proximal colon-specific tumorigenesis driven by microsatellite instability-induced Cre-mediated inactivation of Apc and activation of Kras

   • Yasuo Kawaguchi
   • Takao Hinoi
   • Hideki Ohdan

   Original Article—Alimentary Tract 11 September 2015 Pages: 447 - 457

   

5. Esophageal motility after peroral endoscopic myotomy for achalasia

   • Yue Hu
   • Meng Li
   • Haibiao Bao

   Original Article—Alimentary Tract 25 October 2015 Pages: 458 - 464

   

6. Factors affecting recurrence and prognosis after R0 resection for colorectal cancer with peritoneal metastasis

   • Harunobu Sato
   • Koutaro Maeda
   • Hiroshi Takahashi

   Original Article—Alimentary Tract 16 September 2015 Pages: 465 - 472

   

7. Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features

   • Fukiko Kawai-Kitahata
   • Yasuhiro Asahina
   • Mamoru Watanabe

   Original Article—Liver, Pancreas, and Biliary Tract 09 November 2015 Pages: 473 - 486

   

8. Hepatitis B surface antigen seroclearance during nucleoside analogue therapy: surface antigen kinetics, outcomes, and durability

   • Wai-Kay Seto
   • Ka-Shing Cheung
   • Man-Fung Yuen

   Original Article—Liver, Pancreas, and Biliary Tract 07 October 2015 Pages: 487 - 495

   

9. Appropriate use of virtual touch quantification and FibroScan® M and XL probes according to the skin capsular distance

   • Erina Kumagai
   • Keiko Korenaga
   • Sumio Watanabe

   Original Article—Liver, Pancreas, and Biliary Tract 13 October 2015 Pages: 496 - 505

   

10. Is serum HER2 ECD a predictive biomarker for response to trastuzumab in advanced gastric cancer?

    • Takeshi Yamada
    • Yoshiyuki Yamamoto
    • Ichisnosuke Hyodo

    Letter to the Editor 18 February 2016 Pages: 506 - 507

11. Reply to the letter by Takeshi Yamada et al. concerning “Is serum HER2 ECD a predictive biomarker for response to trastuzumab in advanced gastric cancer?”

    • Jun Zhou
    • Zhi Peng
    • Lin Shen

    Letter to the Editor 20 February 2016 Pages: 508 - 508

12. Erratum to: Predictive value of serum HER2 ECD in patients with HER2-positive advanced gastric cancer treated with trastuzumab plus chemotherapy

    • Jun Zhou
    • Zhi Peng
    • Lin Shen

    Erratum 08 March 2016 Pages: 509 - 510